Epinephrine Injection
Product Images NDC 50090-5254

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 50090-5254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

Chemical structure diagram of epinephrine, showing its molecular components including a benzene ring with two hydroxyl groups and a side chain containing a hydroxyl group, a methylated amine, and other atoms consistent with the epinephrine molecule.*

FDA Label Image

Trainer Image 2 (Image 10)

Instructional illustration showing hands removing the blue cap from an Epinephrine 0.15 mg/0.3 mL injection auto-injector device. The image includes a yellow arrow indicating the direction to pull the cap off before use.*

FDA Label Image

Trainer Image 3 (Image 11)

An instructional illustration showing a person holding an epinephrine auto-injector near the outer thigh, demonstrating the correct administration site. A yellow arrow points toward the thigh, indicating the direction for injection.*

FDA Label Image

Trainer Image 4 (Image 12)

Illustration of a hand holding an epinephrine autoinjector device, demonstrating the grip and positioning for administration. The device is held with a pressed-down thumb near the needle end, typically used for intramuscular or subcutaneous injection.*

FDA Label Image

Trainer Image 5 (Image 13)

An instructional image showing hands removing a blue safety cap from a prefilled Epinephrine injection device, 0.15 mg/0.3 mL, labeled by A-S Medication Solutions for intramuscular or subcutaneous use.*

FDA Label Image

Trainer Injector (Image 14)

An instructional diagram showing step-by-step usage directions for an Epinephrine injection device. The illustrations demonstrate removing the cap, positioning the device for injection, performing the injection, and proper disposal. The device includes warning and instructional text along with visual cues for correct administration technique.*

FDA Label Image

0.3 mg Injector (Image 15)

Epinephrine 0.15 mg/0.3 mL injection autoinjector label by A-S Medication Solutions. The label includes step-by-step illustrated instructions for intramuscular or subcutaneous administration, warnings such as not using if the tamper-evident seal is broken, and advice to get emergency medical help after use. The label is predominantly orange with black and white instructional graphics.*

FDA Label Image

0.15 mg Injector (Image 16)

Epinephrine injection auto-injector for intramuscular or subcutaneous use, strength 0.15 mg/0.3 mL, from A-S Medication Solutions. The label includes step-by-step emergency usage instructions with illustrations and cautions in multiple colors, including green and orange on the device case.*

FDA Label Image

Ppi Image (Image 2)

Illustration of Epinephrine Injection auto-injectors by A-S Medication Solutions showing two dosage strengths: 0.3 mg with a yellow label and yellow cap, and 0.15 mg with a green label and green cap. The image highlights the blue safety release and orange tip features of both auto-injectors, with views both capped and uncapped.*

FDA Label Image

Ppi Ifu Image 1 (Image 3)

An instructional illustration demonstrating how to open a medicinal injection device. The left panel shows a person gripping the device with one hand and twisting off the yellow cap with the other. The right panel depicts the person pulling the cap away from the device, indicated by a yellow arrow showing direction. The images guide users on removing the cap before use.*

FDA Label Image

Ppi Ifu Image 2 (Image 4)

An instructional illustration showing a person removing the cap from a prefilled epinephrine auto-injector, labeled with the number 1 indicating the first step in the injection process.*

FDA Label Image

Ppi Ifu Image 3 (Image 5)

Illustration showing a hand holding an epinephrine auto-injector pen, with a yellow arrow pointing toward the outer thigh, indicating the injection site for intramuscular administration.*

FDA Label Image

Ppi Ifu Image 4 (Image 6)

A photo showing a person's hand holding an epinephrine auto-injector device against their upper thigh. The image demonstrates proper grip of the epinephrine injection device, typically used for intramuscular or subcutaneous administration in emergency situations.*

FDA Label Image

Ppi Ifu Image 5 (Image 7)

An instructional image showing a hand holding an EpiPen injection device with the orange tip pointed outward. A yellow arrow next to the hand indicates the direction for administering the injection, likely illustrating proper use for intramuscular or subcutaneous injection of Epinephrine.*

FDA Label Image

Ppi Ifu Image 6 (Image 8)

FDA Label Image

Trainer-ifu Image (Image 9)

Illustration of the Epinephrine injection trainer device showing labeled parts: a grey cap marked 'do not remove until ready for use,' an orange tip, and a blue safety release also labeled 'do not remove until ready for use.' The image provides visual instructions for handling the device components.*

FDA Label Image

Label Image (Lbl500905254)

Label for Epinephrine Injection, 0.15 mg/0.3 mL, provided by A-S Medication Solutions. The label includes dosage form as single-dose auto-injectors, storage instructions to keep at 68 to 77 degrees Fahrenheit away from heat and light, and states the package contains one injector and one trainer. The product is distributed by A-S Medication Solutions, Libertyville, Illinois. The NDC is 50090-5254-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.